EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Echocardiographic Pulmonary–Left Atrial Ratio and Epicardial Adipose Tissue as Noninvasive Markers of Obstructive Sleep Apnea

Yemlihan Ceylan iD, Mehmet Hakan Bilgin iD

Echocardiography · 2026-03 · 43 (3)

DOI: 10.1111/echo.70425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Echocardiography, online erschienen am 25.03.2026. Verfasst von Yemlihan Ceylan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Epicardial Adipose Tissue, Echocardiography, Heart Atria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obstructive sleep apnea syndrome (OSAS) is linked to pulmonary hypertension and cardiovascular risk, yet simple echocardiographic indices related to cardiopulmonary hemodynamics and cardiometabolic burden are limited. We evaluated ePLAR and epicardial adipose tissue (EAT) thickness as complementary, noninvasive echocardiographic markers associated with OSAS presence and severity in newly diagnosed patients.

Methods

In this cross‐sectional study, 63 polysomnography‐confirmed OSAS patients and 63 controls with a similar distribution of age, sex, and major comorbidities underwent transthoracic echocardiography. OSAS severity was classified as mild, moderate, or severe. ePLAR (TRVmax/E/e′) and EAT were measured. Diagnostic performance was assessed by ROC analysis (apparent discrimination), and prediction models for severe OSAS were fitted using Firth penalized logistic regression with bootstrap optimism correction.

Results

OSAS patients had higher EAT (0.62 ± 0.11 vs. 0.53 ± 0.06 cm) and ePLAR (0.37 ± 0.09 vs. 0.23 ± 0.04 m/s) than controls (both p < 0.001). Within OSAS, both measures increased stepwise with severity ( p < 0.001). In internally validated models, adding ePLAR and/or EAT to age/sex/BMI improved discrimination for severe OSAS.

Conclusions

EPLAR and EAT were associated with OSAS presence and severity and showed good apparent discrimination for severe OSAS in this cohort; these findings are hypothesis‐generating and require external validation in clinically representative populations before any clinical implementation. Trial Registration This study was observational and cross‐sectional in design and was not registered in a clinical trial registry because it was not an interventional clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveEpicardial Adipose TissueEchocardiographyHeart AtriaAdipose TissueHumansFemaleMaleCross-Sectional StudiesMiddle AgedPolysomnographySeverity of Illness IndexPericardium

Stichwörter der Autor:innen

cardiovascular riskechocardiographyepicardial adipose tissueobstructive sleep apneapulmonary hypertension

Autor:innen und Institutionen

  • Department of Cardiology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
  • Department of Pulmonary Diseases, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.

ORCID-Profile: Yemlihan Ceylan, Mehmet Hakan Bilgin

Zitieren

APA

Ceylan, Y., & Bilgin, M. H. (2026). Echocardiographic Pulmonary–Left Atrial Ratio and Epicardial Adipose Tissue as Noninvasive Markers of Obstructive Sleep Apnea. Echocardiography, 43(3). https://doi.org/10.1111/echo.70425

Vancouver

Ceylan Y, Bilgin MH. Echocardiographic Pulmonary–Left Atrial Ratio and Epicardial Adipose Tissue as Noninvasive Markers of Obstructive Sleep Apnea. Echocardiography. 2026;43(3). doi:10.1111/echo.70425

BibTeX
@article{Ceylan2026,
  author = {Ceylan, Yemlihan and Bilgin, Mehmet Hakan},
  title = {Echocardiographic Pulmonary–Left Atrial Ratio and Epicardial Adipose Tissue as Noninvasive Markers of Obstructive Sleep Apnea},
  journal = {Echocardiography},
  year = {2026},
  volume = {43},
  number = {3},
  doi = {10.1111/echo.70425}
}
Kostenlos starten →